Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Leukemia
|
November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype
A Clipson, M Wang, L de Leval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes
C Laurent, A Delas, P Gaulard, et al.
Blood Advances
|
August 4, 2025
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study
Olivier Tournilhac, Krimo Bouabdallah, Solene Lecolant, et al.
Blood
|
December 2, 2025
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study
Andrew L Feldman, Surendra Dasari, Lisa M Rimsza, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
ESMO Open
|
September 15, 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
P Hofman, F Calabrese, I Kern, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Leukemia
|
November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype
A Clipson, M Wang, L de Leval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes
C Laurent, A Delas, P Gaulard, et al.
Blood Advances
|
August 4, 2025
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study
Olivier Tournilhac, Krimo Bouabdallah, Solene Lecolant, et al.
Blood
|
December 2, 2025
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study
Andrew L Feldman, Surendra Dasari, Lisa M Rimsza, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
ESMO Open
|
September 15, 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
P Hofman, F Calabrese, I Kern, et al.
Page
of 8